Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -4.307% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) Cc1ccc(-n2c(C)cn(C(=O)c3ccccc3)c2=S)cc1
(b) CCCC(C)n1[nH]c(=O)c2c(C)cc(C)nc21
(c) CCOC(=O)c1c(C)[nH]c(C(=O)COC(=O)c2ccccc2NC(=O)c2ccco2)c1C
Answer: a. Cc1ccc(-n2c(C)cn(C(=O)c3ccccc3)c2=S)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-n2c(C)cn(C(=O)c3ccccc3)c2=S)cc1
Cc1ccc(-n2c(C)cn(C(=O)c3ccccc3)c2=S)cc1
[4-methyl-3-(4-methylphenyl)-2-sulfanylideneimidazol-1-yl]-phenylmethanone